Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 34 MAPLE ST MILFORD MA 01757-3604 |
Tel: | N/A |
Website: | https://www.waters.com |
IR: | See website |
Key People | ||
Udit Batra President, Chief Executive Officer, Director | Amol Chaubal Chief Financial Officer, Senior Vice President | Belinda G. Hyde Senior Vice President - Global Human Resources |
Jianqing Y. Bennett Senior Vice President - TA Instruments Division | Christos Ross Interim Senior Vice President - Waters Division | Caspar Tudor Director of Investor Relations |
Business Overview |
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments. |
Financial Overview |
For the fiscal year ended 31 December 2023, Waters Corp revenues decreased 1% to $2.96B. Net income decreased 9% to $642.2M. Revenues reflect Waters Instrument Systems segment decrease of 8% to $1.11B, China segment decrease of 22% to $440.7M, Japan segment remaining flat at $167.2M. Net income also reflects Interest Expense increase from $48.8M to $98.9M (expense), Selling and administrative expenses increase of 6% to $659M (expense). |
Employees: | 7,900 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $20,360M as of Dec 31, 2023 |
Annual revenue (TTM): | $2,956M as of Dec 31, 2023 |
EBITDA (TTM): | $983.97M as of Dec 31, 2023 |
Net annual income (TTM): | $642.23M as of Dec 31, 2023 |
Free cash flow (TTM): | $442.18M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,960M as of Dec 31, 2023 |
Shares outstanding: | 59,309,762 as of Mar 25, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |